This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cramer's 'Mad Money' Recap: Safe Harbors for Investment

Stocks in this article: FHN AA DIS DFS EBAY MMM BBT KEY FGM NPSP EXAS HD BAC ACN MHP GLD IBM BRK.B EMR SLV HCBK

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK ( TheStreet) -- Investors need safe places to put their money on down days like today, Jim Cramer told "Mad Money" viewers Monday, as he kicked off a weeklong series of top investing trends for 2013.

Cramer said these trends will be the rising tides that lift all boats and will be the safe places to invest as Washington will likely dominate the headlines again soon.

Cramer's first investing theme for 2013? The return of banking.

He said after years of fighting to survive, the banks have finally raised enough capital and have dealt with their bad loans, making them once again investable. As the cloud begins to lift on the sector, Cramer said those in the strongest position will be the regional banks such as First Horizon (FHN) and BB&T (BBT).

His favorite regional player remains KeyCorp (KEY), a stock he owns for his charitable trust, Action Alerts PLUS .

Cramer's next big theme for 2013 is the return of the auto market, something that bodes well for both Ford Motor (F) and General Motors (GM).

Cramer said the U.S. market grew throughout 2012, but the main stumbling block for the automakers was Europe. With Europe finally beginning to stabilize and both companies making aggressive cost-cutting efforts, Cramer said the automakers should be poised to prosper from a global economic recovery.

Executive Decision

In the "Executive Decision" segment, Cramer spoke with Dr. Francois Nader, president and CEO of NPS Pharmaceuticals (NPSP), an orphan-drug maker that's popped 31% after Cramer first recommended it in September. Since then shares have pulled back and Cramer's taking a second look as the company prepares to present its latest data on Wednesday.

Nader commented on the price tag of his company's most recent drug, which treats a condition known as short bowel syndrome afflicting only 3,000 to 5,000 patients in the U.S. The treatment, which weighs in at just under $300,000 a year, is actually a tremendous value, said Nader, as it currently costs almost $600,000 a year for patients to stay at the hospital and receive what can be 12 hours a day of IV nutritional supplements.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs